Legal Representation
Attorney
Allison Z. Gifford
USPTO Deadlines
Application History
17 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Dec 16, 2024 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
Dec 16, 2024 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
May 14, 2024 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
Mar 19, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
Mar 19, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Feb 28, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
Feb 28, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
Feb 12, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Feb 7, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Feb 6, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Feb 6, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
Nov 21, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
Nov 21, 2023 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
Nov 21, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Nov 14, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Feb 21, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Feb 18, 2023 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 009
Downloadable computer software related to prescription drug use administered in combination with a drug product for collecting, storing, analyzing, monitoring, and evaluating a patient's clinical symptoms and response profile during the course of treatment of, and the evaluation of a drug for treatment for, eosinophilic esophagitis
Class 042
Providing on-line non-downloadable computer software related to prescription drug use administered in combination with a drug product for collecting, storing, analyzing, monitoring, and evaluating a patient's clinical symptoms and response profile during the course of treatment of, and the evaluation of a drug for treatment for, eosinophilic esophagitis
Classification
International Classes
009
042